The global Retinitis Market, a condition characterized by retinal inflammation, exhibited significant strength in 2021 and is poised to demonstrate a swift compound annual growth rate (CAGR) in revenue over the foreseeable future. The growth of revenue in the retinitis treatment market is primarily underpinned by key drivers, including robust research and development (R&D) endeavors within the field of ophthalmology and a mounting number of clinical trials targeting eye inflammation treatment. https://www.reportsanddata.com/report-detail/retinitis-market